About Automated Radiosynthesis Modules
Radiosynthesis modules are used for synthesis of radioactive compounds through replacing the one or more atoms present in the radioisotope. Basically, it captures and use the energy derived from the ionizing radiation for development of radioisotopes. It is mostly used in the hospitals or other medical facilities with the main aim of producing radiotracers. Radiotracers are used in diagnosis, imaging, and therapeutic use for treating the patients suffering from chronic and fatal medical conditions such as cancer, cardiac issues, and others. These modules are available in semi-automated and automated type. These are commercialized in table top form, which can be readily used across various healthcare facilities and research institutes.
Attributes | Details |
---|
Study Period | 2017-2027 |
Base Year | 2021 |
Unit | Value (USD Million) |
Analyst at AMA Research estimates that Players are mainly concentrated in Europe Players will contribute the maximum growth to Global Automated Radiosynthesis Modules market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.
COMECER S.p.A (Italy), GE Healthcare (US), Siemens Healthcare (Germany), IBA Radiopharma Solutions (Belgium), Optimized Radiochemical Applications (Belgium), Synthra GmbH (Germany), Eckert & Ziegler Group (Germany), Sumitomo Corp (Japan), Sofie Biosciences (US) and Trasis and Scintomics GmbH (Belgium) are some of the key players that are part of study coverage.
Segmentation Overview
AMA Research has segmented the market of Global Automated Radiosynthesis Modules market by Type (Single-photon emission computed tomography and Positron Emission Tomography), Application (Diagnostic, Therapeutic and Research & Development) and Region.
On the basis of geography, the market of Automated Radiosynthesis Modules has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Type, the sub-segment i.e. Fully Automated will boost the Automated Radiosynthesis Modules market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End-User, the sub-segment i.e. Treatment will boost the Automated Radiosynthesis Modules market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Automated Radiosynthesis Modules Market Dynamics:
Attributes | Details |
---|
Growth Drivers | - Rapidly rising prevalence of chronic medical conditions
- Short life of radiotracers, promoting demand for automated radiosynthesis modules
|
Influencing Trends | - Increasing healthcare spending
|
Restraints | - High cost of the radiosynthesis modules
|
Road Blocks / Challenges | - Intense Competition Among Players
|
Gaps & Opportunities | - Continuous development in the nuclear medicine along with new radioisotope production technologies
|
In 2017, the GE Healthcare entered into partnership with the HealthTrust for exclusive providing low-energy (SPECT) and high-energy (PET) radiopharmaceuticals in the United States. Due to this, the HealthTrust member gets access to Life Sciences Core Imaging single-photon emission computed tomography (SPECT).
In June 2018, Trasis and Shertech Laboratories received Marketing Authorization from the U.S. Food and Drug Administration (US FDA) for the [18F] FDG Dual process on AllinOne modules, which is used in PET to diagnose, and monitor treatment of cancers types.
Key Target Audience
Manufacturers of Automated radiosynthesis module and Suppliers of Automated radiosynthesis module
About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.
Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.
The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.